Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: UNIVERSITY OF KANSAS CENTER FOR RESEARCH INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-11 to 2024-04-08
Current total value of award: $22500
Description: FEASIBILITY TESTING FOR SOLID DOSAGE FORM STRATEGY OPTIONS FOR GPR110 AGONIST A8